Oblongichytrium sp. – Marine Microorganism and DHA Source

What is Oblongichytrium sp.?

Oblongichytrium sp. refers to a genus of single-celled marine microorganisms belonging to the group known as thraustochytrids. These are heterotrophic protists phylogenetically related to brown algae, commonly found in seawater and marine sediments. The abbreviation sp. stands for species and indicates that one or more species within this genus have not yet been fully classified.

These microorganisms are renowned for their capacity to produce large quantities of polyunsaturated fatty acids (PUFAs), especially docosahexaenoic acid (DHA), an omega-3 fatty acid of significant nutritional and medical importance.

Biological Classification

Oblongichytrium sp. belongs to the following taxonomic hierarchy:

• Domain: Eukaryota
• Division: Heterokonta (Stramenopiles)
• Class: Labyrinthulomycetes
• Order: Thraustochytriales
• Family: Thraustochytriaceae
• Genus: Oblongichytrium

The cells are characteristically oval to elongated in shape, consistent with the genus name (Latin oblongus = elongated). They reproduce via zoospores and form typical ectoplasmic networks.

Importance of Fatty Acid Production

A defining feature of Oblongichytrium sp. is its high capacity for biosynthesizing DHA (docosahexaenoic acid, C22:6 n-3) and other long-chain PUFAs. These fatty acids are essential for:

• The development and function of the human brain and nervous system
• The health of the eyes, particularly the retina
• The regulation of inflammatory processes in the body
• The cardiovascular health through beneficial effects on blood lipid levels

Since the human body can only synthesize DHA in limited amounts, it must be obtained through diet. Traditionally, DHA has been sourced from fish oil; however, fish themselves obtain DHA through the food chain from marine microorganisms such as thraustochytrids.

Biotechnological and Medical Applications

Oblongichytrium sp. has attracted considerable interest in biotechnology and the nutraceutical industry over recent decades. Key areas of application include:

DHA-Rich Dietary Supplements

Extracts from Oblongichytrium sp. are used as a vegan and vegetarian alternative to fish oil. DHA derived from microalgae and thraustochytrids is used in dietary supplements, fortified foods, and infant formula. This is particularly relevant for individuals who do not consume animal products.

Pharmaceutical and Clinical Relevance

DHA and other omega-3 fatty acids derived from Oblongichytrium sp. are being investigated in medical research for the following therapeutic areas:

• Neurocognitive disorders: Potential protective effects against Alzheimer's disease and other forms of dementia
• Preterm infant nutrition: DHA supplementation to support brain development
• Inflammatory conditions: Omega-3 fatty acids have anti-inflammatory properties and may provide supportive benefit in conditions such as rheumatoid arthritis
• Cardiovascular disease: Reduction of triglycerides and support of overall heart health

Sustainable Production

Compared to extracting DHA from fish oil, fermentative production using Oblongichytrium sp. offers significant ecological advantages. Cultivation in controlled bioreactors provides a sustainable, fish-independent, and low-contaminant DHA source that is free from heavy metals, dioxins, and other marine pollutants.

Cultivation and Fermentation

Oblongichytrium sp. can be cultivated in industrial fermentation processes using carbon sources such as glucose. By optimizing temperature, salinity, pH, and nutrient composition, high DHA yields can be achieved. The biomass is then harvested and the lipid fraction is extracted using various separation methods.

Safety and Regulatory Aspects

DHA-rich oils derived from thraustochytrids, including Oblongichytrium species, have been assessed as safe for human consumption by regulatory bodies including the U.S. Food and Drug Administration (FDA, GRAS status) and the European Food Safety Authority (EFSA). They are used globally in the food and dietary supplement industry.

References

1. Gupta, A. et al. (2012): Docosahexaenoic acid production from microalgae. In: Applied Microbiology and Biotechnology, 93(2), pp. 411-422.
2. Raghukumar, S. (2008): Thraustochytrid marine protists: Production of PUFAs and other emerging technologies. In: Marine Biotechnology, 10(6), pp. 631-640.
3. EFSA Panel on Dietetic Products, Nutrition and Allergies (2010): Scientific Opinion on DHA and ARA and brain development. EFSA Journal 2010;8(10):1796.